Davies Lab

Publications

Davies, SM; Ross, JA. Childhood cancer etiology: recent reports. Pediatric Blood and Cancer. 2003; 40:35-38.

ROSS, JA; DAVIES, SM; ROBISON, LL. Is it possible to catch leukaemia from a cat?. The Lancet. 1994; 344:1580.

ROSS, JA; DAVIES, SM; POTTER, JD; ROBISON, LL. Epidemiology of childhood leukemia, with a focus on infants. Epidemiologic Reviews. 1994; 16:243-272.

DAVIES, SM. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Research. 1993; 53:4781-4783.

Ramsay, NK; Davies, S. Bone marrow transplant for acute leukaemia. Best Practice and Research: Clinical Haematology. 1991; 4:483-510.

Sarkar, N; Myers, KC; Lane, A; Davies, SM; Benoit, SW. Pre-transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients. Pediatric Blood and Cancer. 2024; e30853.

Sabulski, A; Abdullah, S; Luebbering, N; Aunins, B; Castillo, C; Lake, K; Duell, A; Strecker, L; Langenberg, L; Broomhead, W; et al. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma. Haematologica: the hematology journal. 2023; 108:3449-3453.

Auletta, JJ; Holter-Chakrabarty, J; Jain, T; Miller, B; Ward, E; Khera, N; Gomez-Arteaga, A; Hall, A; Nemecek, E; Robb, D; et al. Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and cellular therapy. 2023; 29:739-746.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Diversity After Hematopoietic Stem Cell Transplantation. Journal of Infectious Diseases. 2023; 228:1208-1218.

Auletta, JJ; Khera, N; DeMartino, P; Kelkar, AH; Yusuf, RA; Davies, SM; Knutson, J; Beaver, E; Maloney, A; Majhail, NS. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative. Transplantation and cellular therapy. 2023; 29:713-720.

Koo, J; Ziady, AG; Reynaud, D; Abdullah, S; Luebbering, N; Kahn, S; Langenberg, L; Strecker, L; Lake, K; Dandoy, CE; et al. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023; 29:704.e1-704.e8.

Wang, YM; Abdullah, S; Luebbering, N; Langenberg, L; Duell, A; Lake, K; Lane, A; Hils, B; Silva, OV; Trapp, M; et al. Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood Advances. 2023; 7:5137-5151.

Koo, J; Grom-Mansencal, I; Howell, JC; Rios, JM; Mehta, PA; Davies, SM; Myers, KC. Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. Haematologica: the hematology journal. 2023; 108:2358-2368.

Bartlett, AL; Zhang, G; Wallace, G; McLean, S; Myers, KC; Teusink-Cross, A; Taggart, C; Patel, B; Davidson, R; Davies, SM; et al. Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant. Blood Advances. 2023; 7:4555-4562.

Khandelwal, P; Lounder, DT; Bartlett, A; Haberman, Y; Jegga, AG; Ghandikota, S; Koo, J; Luebbering, N; Leino, D; Abdullah, S; et al. Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica: the hematology journal. 2023; 108:1803-1816.

Phillips, CL; Krupski, C; Khoury, R; Dandoy, CE; Nelson, AS; Galletta, TJ; Faulhaber, A; Davies, SM; Rubinstein, JD. Post CAR T-cell therapy outcomes and management in HSCT-naive patients: a single-center experience. 2023; 2:1151744.

Galletta, TJ; Rubinstein, JD; Krupski, C; Nelson, AS; Khoury, R; Dandoy, CE; Davies, SM; Phillips, CL. Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel. Pediatric Blood and Cancer. 2023; 70:e30271.

Galletta, TJ; Lane, A; Lutzko, C; Leemhuis, T; Cancelas, JA; Khoury, R; Wang, YZ M; Hanley, PJ; Keller, MD; Bollard, CM; et al. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults. Transplantation and cellular therapy. 2023; 29:305-310.

Rubinstein, JD; Breese, EH; Krupski, MC; O'Brien, MM; Dandoy, CE; Mizukawa, B; Khoury, R; Norris, RE; Davies, SM; Phillips, CL. The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL. Transplantation and cellular therapy. 2023; 29:311.e1-311.e7.

Wang, YZ M; Loveless, M; Miller, E; Nelson, AS; Mehta, PA; Davies, SM; Myers, KC. Phenotypes of adults with Fanconi anaemia. British Journal of Haematology. 2023; 201:133-139.

Wang, YZ M; Taggart, CB; Huber, JF; Davies, SM; Smith, DF; Hogenesch, JB; Dandoy, CE. Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant. The Journal of Clinical Investigation. 2023; 133:e167275.

Wang, YM; Taggart, CB; Huber, J; Davies, SM; Smith, DF; Hogenesch, JB; Dandoy, DC E. 167 Earlier Oral Intake in Pediatric Stem Cell Transplant Patients Receiving Time-Restricted Feeding: A Prospective, Randomized Trial. Transplantation and cellular therapy. 2023; 29:s135.

Zhang, G; Odegard, E; Sabulski, DA; Jodele, S; Ziady, A; Seif, AE; Davies, SM; Laskin, B; Blackard, JT. 441 Evolution of BK Polyomavirus in Immunocompromised Pediatric Patients. Transplantation and cellular therapy. 2023; 29:s333-s334.

Sabulski, DA; Myers, K; Davies, SM; Jodele, S. 406 All Eyes on Interferon in Graft Failure after Hematopoietic Stem Cell Transplant. Transplantation and cellular therapy. 2023; 29:s306-s307.

Galletta, TJ; Dong, M; Vinks, AA; Chiang, SC C; Teusink-Cross, A; Marsh, RA; Davies, SM; Mehta, PA; Khandelwal, P. 356 Children Under 2 Years Old Treated with Ruxolitinib for Acute and Chronic Graft-Versus-Host-Disease Demonstrate Variable Pharmacokinetics. Transplantation and cellular therapy. 2023; 29:s271-s272.

Bender, JD; Oquendo-del Toro, H; Benoit, J; Howell, JC; Badia, P; Davies, SM; Grimley, MS; Jodele, S; Phillips, C; Burns, K; et al. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023; 29:130.e1-130.e8.

Sabulski, DA; Siefert, ME; Skala, E; Abdullah, S; Luebbering, N; Myers, K; Odegard, E; Blackard, JT; Seif, AE; Jodele, S; et al. 77 Proteomic Analyses Reveal Molecular Connections That Support the Clinical Association of Cystitis with Thrombotic Microangiopathy in Pediatric Transplant Recipients. Transplantation and cellular therapy. 2023; 29:s64-s65.

Odegard, E; Meeds, H; Kleiboeker, S; Ziady, A; Sabulski, DA; Jodele, S; Seif, AE; Davies, SM; Laskin, B; Blackard, JT. 429 BK Polyomavirus after Pediatric Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023; 29:s324-s325.

Koo, DJ; Reynaud, D; Ziady, A; Kahn, S; Abdullah, S; Luebbering, N; Strecker, L; Lake, KE; Giordullo, L; Ibrahimova, A; et al. 166 Reduced Sphingosine-1-Phosphate Leads to Hypoxemia and Lung Injury after Hematopoietic Stem Cell Transplant. Transplantation and cellular therapy. 2023; 29:s134.

Auletta, JJ; Sandmaier, BM; Jensen, E; Majhail, NS; Knutson, J; Nemecek, E; Ajayi-Hackworth, F; Davies, SM. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. Transplantation and cellular therapy. 2022; 28:802-809.

Sabulski, A; Abdullah, S; Luebbering, N; Aunins, B; Castillo, C; Lake, K; Duell, A; Strecker, L; Giordullo, L; Broomhead, W; et al. Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant. Haematologica: the hematology journal. 2022; 107:2950-2954.

Myers, KC; Davies, SM; Lutzko, C; Wahle, R; Aubert, G; Amano, T; Amano, M; Yu, H; Ko, MS H. Successful Ex Vivo Telomere Elongation with Exg-001 in a Patient with a Dyskeratosis Congenita. Blood. 2022; 140:1895-1896.

Sabulski, A; Wallace, G; Lane, A; Davies, SM; Myers, KC. Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients. Bone Marrow Transplantation. 2022; 57:1589-1591.

Addison, J; Razzaghi, H; Bailey, C; Dickinson, K; Corathers, SD; Hartley, DM; Utidjian, L; Carle, AC; Rhodes, ET; Alonso, GT; et al. Testing an Automated Approach to Identify Variation in Outcomes among Children with Type 1 Diabetes across Multiple Sites. Pediatric Quality and Safety. 2022; 7:e602.

Khandelwal, P; Chaturvedi, V; Owsley, E; Efebera, YA; Choe, H; Bostic, M; Kumchala, P; Rajgolikar, G; Ranganathan, P; Garzon, R; et al. Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD. Transplantation Reports. 2022; 7:100100.

Chiang, SC C; Owsley, E; Panchal, N; Chaturvedi, V; Terrell, CE; Jordan, MB; Mehta, PA; Davies, SM; Akeno, N; Booth, C; et al. Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Blood. 2022; 140:706-715.

Sabulski, A; Arcuri, G; Szabo, S; Care, MM; Dandoy, CE; Davies, SM; Jodele, S. Cerebral vascular injury in transplant-associated thrombotic microangiopathy. Blood Advances. 2022; 6:4310-4319.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; et al. Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood Advances. 2022; 6:2897-2907.

Sabulski, A; Grier, DD; Myers, KC; Davies, SM; Rubinstein, JD. Acute myeloid leukemia in SRP54-mutated congenital neutropenia. 2022; 3:521-525.

Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al. Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14:2040.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, AA; Jodele, S. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Advances. 2022; 6:1454-1463.

Galletta, TJ; Lane, A; Lutzko, CM; Leemhuis, T; Cancelas, JA; Khoury, R; Wang, YM; Hanley, PJ; Keller, MD; Bollard, CM; et al. 477 Availability of Donor Derived Patient Specific Virus-Specific T-Cells (VSTs) Is Not Associated with Differences in Outcomes As Compared to Frontline Administration of Third Party Vsts for the Management of Viral Infections after Pediatric Hematopoietic Stem Cell Transplant. Transplantation and cellular therapy. 2022; 28:s374-s375.

Gardner, JC; Courter, JD; Dandoy, CE; Davies, SM; Teusink-Cross, A. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients. Transplantation and cellular therapy. 2022; 28:167.e1-167.e5.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, A; Jodele, S. 187 Eculizumab Precision Dosing Algorithm for TA-TMA in Children and Young Adults Undergoing Stem Cell Transplant. Transplantation and cellular therapy. 2022; 28:s154-s155.

Vasu, S; Bostic, M; Zhao, Q; Sharma, N; Puto, M; Knight, S; Scott, D; Guzman, R; Kromer, M; Tackett, K; et al. Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults. Blood Advances. 2022; 6:1342-1349.

Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and cellular therapy. 2022; 28:116.e1-116.e7.

Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al. Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation. 2022; 106:412-419.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients. Editor, Roux S. Microbiology Resource Announcements. 2022; 11:e0105321.

Furutani, E; Liu, S; Galvin, A; Steltz, S; Malsch, MM; Loveless, SK; Mount, L; Larson, JH; Queenan, K; Bertuch, AA; et al. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Advances. 2022; 6:297-306.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Optimized amplification of BK polyomavirus in urine. Journal of Virological Methods. 2022; 299:114319.

Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA. Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. British Journal of Clinical Pharmacology. 2022; 88:115-127.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Reply to: Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2022; 69:e29432.

Arnold, DE; Emoto, C; Fukuda, T; Dong, M; Vinks, AA; Lane, A; McIntosh, K; Neumeier, L; Lankester, AC; Achini, F; et al. A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Bone Marrow Transplantation. 2021; 56:3029-3031.

Kennedy, AL; Myers, KC; Bowman, J; Gibson, CJ; Camarda, ND; Furutani, E; Muscato, GM; Klein, RH; Ballotti, K; Liu, S; et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nature Communications. 2021; 12:1334.

Walkup, LL; Myers, KC; Willmering, MM; Mehta, PA; Nelson, AS; Fleck, RJ; Woods, JC; Davies, SM; Towe, CT. Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita. American Journal of Respiratory and Critical Care Medicine. 2021; 204:1340-1343.

Sabulski, A; Myers, KC; Bleesing, JJ; Duell, A; Lane, A; Teusink-Cross, A; Davies, SM; Jodele, S. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Advances. 2021; 5:4594-4604.

Davies, SM. Grasping the sword of Damocles. Blood. 2021; 138:1792-1793.

Wallace, G; Rosen, N; Towbin, AJ; Jodele, S; Myers, KC; Davies, SM; Flannery, A; Gurria, JP. Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough. Journal of Pediatric Surgery. 2021; 56:2073-2077.

Koo, J; Teusink-Cross, A; Davies, SM; Jodele, S; Dandoy, CE. Single-center results reporting improved hematopoietic stem cell mobilization success in pediatric and young adult patients with solid tumors and lymphoma. Pediatric Blood and Cancer. 2021; 68:e29319.

Rubinstein, JD; Zhu, X; Leemhuis, T; Pham, G; Ray, L; Emberesh, S; Jodele, S; Thomas, S; Cancelas, JA; Bollard, CM; et al. Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted. Blood Advances. 2021; 5:3309-3321.

Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA. Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. British Journal of Haematology. 2021; 194:e84-e89.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2021; 68:e29231.

McGrady, ME; Mara, CA; Geiger-Behm, K; Ragsdale, J; Davies, SM; Schwartz, LA; Phipps, S; Pai, AL H. Psychometric evaluation of the brief RCOPE and relationships with psychological functioning among caregivers of children undergoing hematopoietic stem cell transplant. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer. 2021; 30:1457-1465.

Levine, JE; Grupp, SA; Pulsipher, MA; DIetz, AC; Rives, S; Myers, GD; August, KJ; Verneris, MR; Buechner, J; Laetsch, TW; et al. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Journal for ImmunoTherapy of Cancer. 2021; 9:e002287.

Ibrahimova, A; Davies, SM; Lane, A; Jordan, MB; Lake, K; Litts, B; Chaturvedi, V; Owsley, E; Myers, KC; Nelson, AS; et al. α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease. Pediatric Blood and Cancer. 2021; 68:e28968.

Sabulski, A; Szabo, S; Myers, KC; Davies, SM; Jodele, S. Testicular thrombotic microangiopathy: An unrecognized complication. Pediatric Blood and Cancer. 2021; 68:e29128.

Dandoy, CE; Davies, SM; Ahn, KW; He, Y; Kolb, AE; Levine, J; Bo-Subait, S; Abdel-Azim, H; Bhatt, N; Chewing, J; et al. Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children. Haematologica: the hematology journal. 2021; 106:1839-1845.

Wallace, G; Khandelwal, P; Myers, KC; Perentesis, EM R; Lane, A; Teusink-Cross, A; Smiley, K; Davies, SM; Jodele, S. Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease. Bone Marrow Transplantation. 2021; 56:1441-1444.

Jung, M; Mehta, PA; Jiang, CS; Rosti, RO; Usleaman, G; da Rosa, JM C; Lach, FP; Goodridge, E; Auerbach, AD; Davies, SM; et al. Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia. British Journal of Haematology. 2021; 193:971-975.

Ryan, TD; Moore, RA; Lang, SM; Khoury, P; Dandoy, CE; Davies, SM; Taylor, MD. Rapid cardiac MRI protocol for cardiac assessment in paediatric and young adult patients undergoing haematopoietic stem cell transplant: a feasibility study. Cardiology in the Young. 2021; 31:973-978.

Kumar, S; Nattamai, KJ; Hassan, A; Amoah, A; Karns, R; Zhang, C; Liang, Y; Shimamura, A; Florian, MC; Bissels, U; et al. Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome. Leukemia. 2021; 35:1751-1762.

Wang, YZ M; Howell, JC; Grimley, MS; Lane, A; Davies, SM; Myers, KC. Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatric Transplantation. 2021; 25:e13983.

Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; et al. Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Haematologica: the hematology journal. 2021; 106:1321-1329.

Stefanski, KJ; Anixt, JS; Goodman, P; Bowers, K; Leisenring, W; Scott Baker, K; Burns, K; Howell, R; Davies, S; Robison, LL; et al. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. Journal of the National Cancer Institute. 2021; 113:481-495.

Khandelwal, P; Yeh, RF; Yu, L; Lane, A; Dandoy, CE; El-Bietar, J; Davies, SM; Grimley, MS. Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Transplantation. 2021; 105:891-896.

Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; et al. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13:1368.

Ruiz-Torres, S; Brusadelli, MG; Witte, DP; Wikenheiser-Brokamp, KA; Sauter, S; Nelson, AS; Sertorio, M; Chlon, TM; Lane, A; Mehta, PA; et al. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell. 2021; 28:424-435.e6.

Tamburro, RF; Cooke, KR; Davies, SM; Goldfarb, S; Hagood, JS; Srinivasan, A; Steiner, ME; Stokes, D; DiFronzo, N; El-Kassar, N; et al. Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary. Annals of the American Thoracic Society. 2021; 18:381-394.

Koo, J; Teusink-Cross, A; Davies, SM; Jodele, S; Dandoy, CE. 276 Single Center Results to Improve Peripheral Blood Stem Cell Mobilization Success in Pediatric and Young Adult Patients. Transplantation and cellular therapy. 2021; 27:s242.

Lipps, D; Zhu, X; Lutzko, C; Leemhuis, T; Cancelas, JA; Jodele, S; Keller, MD; Bollard, CM; Hanley, PJ; Rubinstein, JD; et al. 433 T Cell Co-Stimulatory Blockade By CTLA4-Ig Does Not Appear to Impact the Clinical Efficacy of Viral Specific T Cell Therapy in Pediatric Patients after HSCT. Transplantation and cellular therapy. 2021; 27:s357-s358.

Wang, YM; Lipps, D; Wilson, B; Leemhuis, T; Cancelas, JA; Lane, A; Badia, P; Davies, SM; Dandoy, CE. 180 Beware Cells That Come in the Night: Time of Stem Cell Infusion As Risk Factor for Primary Graft Failure. Transplantation and cellular therapy. 2021; 27:s166-s167.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; Cancelas, JA; et al. 91 Scheduled Donor-Derived Viral Specific T-Cells for Prophylaxis Against Double Stranded DNA Viral Infection after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2021; 27:s87-s88.

Sabulski, A; Davies, SM; Paulsen, G; Marsh, R; Chandra, S. BCG-osis and Hematopoietic Cell Transplant for Primary Immunodeficiencies. Journal of Clinical Immunology. 2021; 41:491-494.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Genotypes in Two Patients after Hematopoietic Cell Transplant. Editor, Roux S. Microbiology Resource Announcements. 2021; 10:e01122-e01120.

Dandoy, CE; Rotz, S; Alonso, PB; Klunk, A; Desmond, C; Huber, J; Ingraham, H; Higham, C; Dvorak, CC; Duncan, C; et al. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Advances. 2021; 5:1-11.

Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; et al. Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.

Chandra, S; Chandrakasan, S; Dávila Saldaña, BJ; Bleesing, JJ; Jordan, MB; Kumar, AR; Grimley, MS; Krupski, C; Davies, SM; Khandelwal, P; et al. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation. Journal of Clinical Immunology. 2021; 41:89-98.

Laskin, BL; Denburg, MR; Furth, SL; Moatz, T; Altrich, M; Kleiboeker, S; Lutzko, C; Zhu, X; Blackard, JT; Jodele, S; et al. The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation. Clinical Infectious Diseases. 2020; 71:3044-3054.

Nelson, AS; Heyenbruch, D; Rubinstein, JD; Sabulski, A; Jodele, S; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; et al. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients. Blood Advances. 2020; 4:5745-5754.

Reddy, P; Davies, S; Majhail, N; Sandmaier, B; Hari, P; Cutler, C. In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults ". Blood Advances. 2020; 4:5431-5432.

Rubinstein, JD; Krupski, C; Nelson, AS; O'Brien, MM; Davies, SM; Phillips, CL. Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia. Biology of Blood and Marrow Transplantation. 2020; 26:e280-e285.

Sabulski, A; Davies, SM; Paulsen, G; Kumar, A; Grimley, M; Chandra, S. Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant. Journal of Clinical Immunology. 2020; 40:1171-1175.

Davies, SM; Jordan, MB; Marsh, R. A tribute to the life and work of Alexandra (Lisa) H. Filipovich, 1951-2020. Pediatric Blood and Cancer. 2020; 67:e28510.

Badia, P; Andersen, H; Haslam, D; Nelson, AS; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; Hickey, V; et al. Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 2020; 26:1704-1710.

Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al. CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study. Bone Marrow Transplantation. 2020; 55:1552-1559.

Rubinstein, JD; Zhu, X; Lutzko, C; Leemhuis, T; Cancelas, JA; Jodele, S; Bollard, CM; Hanley, PJ; Davies, SM; Grimley, MS; et al. Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy. Blood Advances. 2020; 4:3252-3257.

Erez, DL; Denburg, MR; Afolayan, S; Jodele, S; Wallace, G; Davies, SM; Seif, AE; Bunin, N; Laskin, BL; Sullivan, KE. Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9. Biology of Blood and Marrow Transplantation. 2020; 26:1266-1272.

Blackard, JT; Davies, SM; Laskin, BL. BK polyomavirus diversity-Why viral variation matters. Reviews in Medical Virology. 2020; 30:e2102.

Phillips, CL; Lane, A; Gerbing, RB; Alonzo, TA; Wilkey, A; Radloff, G; Lange, B; Gamazon, ER; Dolan, ME; Davies, SM. Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group. Clinical Cancer Research. 2020; 26:2891-2897.

Stark, JE; Opoka, AM; Fei, L; Zang, H; Davies, SM; Wong, HR; Alder, MN. Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation. Editor, Reddy SV. PloS one. 2020; 15:e0233738.

Teusink-Cross, A; Davies, SM; Grimley, MS; Chandra, S; Flannery, A; Dandoy, CE; Nelson, AS; Marsh, RA; Jacoby, B; Lane, A; et al. Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience. Pediatric Transplantation. 2020; 24:e13692.

Davies, SM; Iannone, R; Alonzo, TA; Wang, YC; Gerbing, R; Soni, S; Kolb, EA; Meshinchi, S; Orchard, PJ; Burns, LJ; et al. A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study. Biology of Blood and Marrow Transplantation. 2020; 26:712-717.

Rubinstein, JD; Nelson, AS; Krupski, C; O'Brien, W; Taylor, JM; Badgett, TC; Huang, M; Davies, SM; Phillips, CL. Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities. Pediatric Blood and Cancer. 2020; 67:e28199.

Jodele, S; Dandoy, CE; Lane, A; Laskin, B; Laskin, BL; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Blood. 2020; 135:1049-1057.

Jodele, S; Medvedovic, M; Luebbering, N; Chen, J; Dandoy, CE; Laskin, BL; Davies, SM. Interferon-complement loop in transplant-associated thrombotic microangiopathy. Blood Advances. 2020; 4:1166-1177.

Sabulski, A; Aunins, B; Abdullah, S; Luebbering, N; Davies, SM. Circulating Endothelial Cells As a Marker of Vascular Injury in Pediatric Patients. Biology of Blood and Marrow Transplantation. 2020; 26:s144-s145.

Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Pediatric Blood and Cancer. 2020; 67:e28126.

Myers, KC; Furutani, E; Weller, E; Siegele, B; Galvin, A; Arsenault, V; Alter, BP; Boulad, F; Bueso-Ramos, C; Burroughs, L; et al. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. The Lancet Haematology. 2020; 7:e238-e246.

Gloude, NJ; Dandoy, CE; Davies, SM; Myers, KC; Jordan, MB; Marsh, R; Kumar, A; Bleesing, JJ; Teusink-Cross, A; Jodele, S. Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation. 2020; 26:s15-s16.

Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.